How much funding has Tenax Therapeutics raised?

Tenax Therapeutics has raised $125.0M in total funding, most recently a Corporate Round.

Who are Tenax Therapeutics's investors?

Tenax Therapeutics's investors include RTW Investments.

When was Tenax Therapeutics founded?

Tenax Therapeutics was founded in 1967.

Where is Tenax Therapeutics headquartered?

Tenax Therapeutics is headquartered in Chapel Hill, North Carolina, United States.

What industry is Tenax Therapeutics in?

Tenax Therapeutics operates in Biotech, Healthcare.

How many employees does Tenax Therapeutics have?

Tenax Therapeutics has 1-10 employees.

Tenax Therapeutics

IPO

Tenax

Public · Chapel Hill, United States · Founded 1967 · $125.0M raised

Biotech

Healthcare

Headquarters: Chapel Hill, North Carolina
Employees: 1–10
Founded: 1967
Business Model: B2B
Website: tenaxthera.com

Total Funding: $125.0M
Last Round: $25.0M Corporate RoundMar 2025
Rounds: 2
Type: Public

About

Tenax Therapeutics is a Phase 3 specialty pharmaceutical company focused on identifying, developing, and commercializing novel therapies for cardiopulmonary diseases including pulmonary arterial hypertension and heart failure. The company leverages clinical insights into pulmonary and cardiovascular disorders to advance its pipeline of treatments for patients with unmet medical needs.

Summary

Tenax Therapeutics is a Biotech company based in Chapel Hill, United States, founded in 1967. It has raised $125.0M in total across 2 rounds, most recently a $25.0M Corporate Round round in Mar 2025. Investors include RTW Investments.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundMar 2025

$25.0M

Mar 2025

Sign up to see all 2 rounds

Corporate Round — per-round amounts, valuations, and who invested in each round.

Investors

RTW Investments

Lead

1 round

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare

Growth Equity·$5.1B·Aug 2022

IVI-RMA

IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...

Valencia, Spain5001–10000Biotech, Healthcare

Private Equity·$3.3B·Apr 2022

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech

Series A·$3.0B·Jan 2022

inVentiv HealthAcquired

inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...

Burlington, United States5001–10000Biotech, Healthcare

Private Equity·$3.0B·May 2017

Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare

Private Equity·$3.0B·Jan 2004

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology

Corporate Round·$2.8B·Jan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

<a href="https://indexed.vc/companies/tenax-therapeutics"><img src="https://indexed.vc/api/badge/company/tenax-therapeutics" alt="Tenax Therapeutics on Indexed.vc" width="260" height="76" /></a>